Correlation Between Seres Therapeutics and 89bio
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and 89bio Inc, you can compare the effects of market volatilities on Seres Therapeutics and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and 89bio.
Diversification Opportunities for Seres Therapeutics and 89bio
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Seres and 89bio is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and 89bio go up and down completely randomly.
Pair Corralation between Seres Therapeutics and 89bio
Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the 89bio. In addition to that, Seres Therapeutics is 1.5 times more volatile than 89bio Inc. It trades about -0.02 of its total potential returns per unit of risk. 89bio Inc is currently generating about 0.01 per unit of volatility. If you would invest 1,035 in 89bio Inc on September 5, 2024 and sell it today you would lose (205.00) from holding 89bio Inc or give up 19.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. 89bio Inc
Performance |
| Timeline |
| Seres Therapeutics |
| 89bio Inc |
Seres Therapeutics and 89bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and 89bio
The main advantage of trading using opposite Seres Therapeutics and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| 89bio vs. Candel Therapeutics | 89bio vs. Cingulate Warrants | 89bio vs. Unicycive Therapeutics | 89bio vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |